Design Therapeutics Inc — Quarterly Cash Flow (NASDAQ:DSGN) | MetaTrader

Open full chart

Financials

Overview Relatórios Statistics Dividends

Quarterly Annual

Total assets 261.63 M252.09 M237.47 M222.89 M211.77 M Total liabilities 9.18 M10 M9.56 M9.85 M12.05 M Total equity 252.45 M242.1 M227.92 M213.04 M199.72 M Total liabilities & shareholders' equities 261.63 M252.09 M237.47 M222.89 M211.77 M Total debt ————— Net debt —————

Notícias

Craig-Hallum inicia cobertura da Design Therapeutics com recomendação de compra

Craig-Hallum initiates Design Therapeutics stock with Buy rating

Leerink Partners eleva Design Therapeutics para Outperform com avanço no pipeline

Leerink Partners upgrades Design Therapeutics stock to Outperform on pipeline progress

Nutex Health Posts Strong Q3 Results, Joins PACS Group, Walmart, Cerence And Other Big Stocks Moving Higher On Thursday - Cipher Mining (NASDAQ:CIFR), Aduro Clean Technologies (NASDAQ:ADUR)

RBC Capital eleva classificação das ações da Design Therapeutics com perspectiva melhorada

Design Therapeutics stock rating upgraded by RBC Capital on improved outlook

Design Therapeutics unveils DT-818 for myotonic dystrophy treatment

Design Therapeutics, Inc. (DSGN) Presents at Cantor Global Healthcare Conference 2025 Tran

Steven Cohen’s Biotech Bets Are Getting Bolder - And Smaller - Invivyd (NASDAQ:IVVD)

Design Therapeutics reports voting results from annual meeting

RBC Capital maintains Design Therapeutics stock rating with $5 target